PRELUDE CAPITAL MANAGEMENT, LLC
Position in TARA — Protara Therapeutics, Inc.
CIK 1387508
NEW YORK, NY
Position in TARA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$74,921
-$18,673 QoQ
Shares Held
19,613
-8.8% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 118 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TARA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. TARA ranks #55 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,590 | $7,776,650 | |
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 | |
| 8 | CGON |
CG Oncology, Inc.
|
10,811 | $768,121 |
All Filings in TARA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,921 | 19,613 | Shares | Other | 2026-08-14 | |
| 2025-09-30 | $93,594 | 21,516 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $69,132 | 22,816 | Shares | Other | 2025-08-14 | |
| 2022-03-31 | $65,775 | 12,872 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $113,771 | 16,855 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $91,032 | 13,155 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $113,958 | 11,700 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||